EC Number |
Substrates |
Organism |
Products |
Reversibility |
---|
3.4.22.B69 | Cbz-Phe-Arg-7-amido-4-methylcoumarin + H2O |
- |
Plasmodium falciparum |
Cbz-Phe-Arg + 7-amino-4-methylcoumarin |
- |
? |
3.4.22.B69 | D-Val-Leu-Arg-7-amido-4-methylcoumarin + H2O |
- |
Plasmodium falciparum |
D-Val-Leu-Arg + 7-amino-4-methylcoumarin |
- |
? |
3.4.22.B69 | D-Val-Leu-Arg-7-amido-4-methylcoumarin + H2O |
- |
Plasmodium falciparum W2 |
D-Val-Leu-Arg + 7-amino-4-methylcoumarin |
- |
? |
3.4.22.B69 | Hemoglobin + H2O |
- |
Plasmodium falciparum |
? |
- |
? |
3.4.22.B69 | high molecular weight kininogen + H2O |
- |
Plasmodium falciparum |
Met-Lys-bradykinin + Lys-bradykinin + bradykinin + ? |
- |
? |
3.4.22.B69 | more |
the falcipain-2 prodomain efficiently inhibits falcipain-2, falcipain-2', berghepain-2, falcipain-3, cathepsin K, cathepsin L, cathepsin B, and cruzain, but it does not inhibit cathepsin C, pepsin, alpha-chymotrypsin, and collagenase |
Plasmodium falciparum |
? |
- |
? |
3.4.22.B69 | N-benzyloxycarbonyl-Leu-Arg 7-amido-4-methylcoumarin + H2O |
- |
Plasmodium falciparum |
N-benzyloxycarbonyl-Leu-Arg + 7-amino-4-methylcoumarin |
- |
? |
3.4.22.B69 | VLK-4-nitroanilide + H2O |
- |
Plasmodium falciparum |
VLK + 4-nitronaniline |
- |
? |
3.4.22.B69 | Z-Leu-Arg-7-amido-4-methylcoumarin + H2O |
- |
Plasmodium falciparum |
Z-Leu-Arg + 7-amino-4-methylcoumarin |
- |
? |
3.4.22.B69 | Z-Phe-Arg-7-amido-4-methylcoumarin + H2O |
- |
Plasmodium falciparum |
Z-Phe-Arg + 7-amino-4-methylcoumarin |
- |
? |